ImmuPharma plc

IMM.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents£0£0£1£2
Short-Term Investments£0£0£0£0
Receivables£0£0£1£0
Inventory£0£0£0£0
Other Curr. Assets£0£1£1£1
Total Curr. Assets£1£1£2£3
Property Plant & Equip (Net)£0£0£0£0
Goodwill£0£0£0£0
Intangibles£0£0£0£0
Long-Term Investments£0£1£1£2
Tax Assets£0£0-£1-£2
Other NC Assets£0£0£1£2
Total NC Assets£0£1£2£3
Other Assets£0£0£0£0
Total Assets£1£3£4£6
Liabilities
Payables£1£1£1£1
Short-Term Debt£0£0£0£0
Tax Payable£0£0£0£0
Deferred Revenue£0£0-£0-£0
Other Curr. Liab.£1£1£1£1
Total Curr. Liab.£2£2£1£2
LT Debt£0£0£0£0
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£0£0£0£0
Total NC Liab.£0£0£1£1
Other Liabilities£0£0-£1-£1
Cap. Leases£0£0£0£0
Total Liabilities£2£2£1£2
Equity
Pref Stock£0£0£0£0
Common Stock£30£30£29£28
Retained Earnings-£66-£64-£61-£57
AOCI£0£6£6£5
Other Equity£36£29£29£27
Total Equity-£1£1£3£4
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£1£3£4£6
Net Debt-£0-£0-£1-£2